Title | Calcium Channel Blockers |
---|---|
Course | Advanced Medicinal Chemistry |
Institution | Nottingham Trent University |
Pages | 15 |
File Size | 973.7 KB |
File Type | |
Total Downloads | 78 |
Total Views | 167 |
Dr. Duffy...
05/03/2017
CHEM30320:
Advanced Medicinal Chemistry
Dr. Liam Duffy: [email protected]
Topic 2: Calcium channel blockers: treatment of angina and hypertension
1
05/03/2017
Angina • Usually a symptom of Coronary Heart Disease: responsible for 15% of male deaths and 10% of female deaths in 2014 (total cardiovascular 28, 26%) - UK data • ‘Heavy’ or tight chest pain that results from oxygen deficiency in cardiac muscle (reduced blood supply) • Prevalence increasing with ageing population (effects over 55’s and males to a higher degree) Risk Factors include: - Hypertension - Smoking - Diabetes - Obesity - Lack of exercise
Arterial Occlusion
1 atm = 760 mmHg • Occlusion causes increase in b.p. • If blood volume to tissues decreases, so does O2 supply to muscles
2
05/03/2017
Structure of the Heart and ECG Basics
To pump effectively the heart needs a constant, well oxygenated blood supply
The Role of Calcium in Myocardial Contraction Extracellular [Ca2+] ~ 10,000 fold Heart muscle cell membrane Intracellular region
3
05/03/2017
Voltage Dependent/Gated Calcium Channels • Embedded in membrane of excitable muscle and neuron cells • Controlled by changes in electrical potential across cell membrane • ‘Gate’ opens when activated by ‘depolarized potentials’ • Influx of Ca2+ ions results in muscular contraction
Almost all CCBs either preferentially or exclusively block voltage dependant calcium channels (VDCC’s)
Calcium Channel Blockers (CCB’s)
1) Reduce heart rate by lowering electrical activity (undesired negative inotropic effects vary from drug to drug). 2) Decrease systemic vascular resistance via smooth muscle relaxation (vasodilation) 3) Reduce ‘afterload’ on heart – heart requires less pressure to eject blood into aorta 4) Increase blood volume and O2 supply to cells
4
05/03/2017
Blood vessel overview
CCB’s have little effect on venous smooth muscle Selective vasodilation of arterial smooth muscle avoids negative inotropy (reduced force of contraction). Dihydropyridines mainly target smooth muscle.
CCB Family of Drugs
Cl
NO2 EtO2C
CO2Et
MeO2C N H
N H
nifedipine
CO2Et
O
NH2
amlodipine
OMe H S
H O
NC N
OMe
O N
OMe
O N
diltiazem
verapamil
5
05/03/2017
Synthesis of nifedipine
NO2 EtO2C
CO2Et N H
• Based on a dihydropyridine core • Symmetrical molecule – no chiral centre! • What methods do we know for pyridine construction?
Hantzsch Synthesis
NO2
MeOH, reflux16 h
CHO EtO2C
CO2Et O
O
NO2 EtO2C
CO2Et N H
NH3
Q - Look up the mechanism for the Hantzsch synthesis
Impurities became an issue on larger scale production
6
05/03/2017
Alternative synthesis:
EtO2C
HOAc, piperidine
+ NO2 O
NO2 EtO2C
CO2Et + H2N
CHO O
EtOH, reflux 16 h
NO2 EtO2C
CO2Et N H
Enables isolation of initial condensation product Q – what’s the mechanism of the first step?
Second generation drugs
Cl MeO2C
CO2Et N H
O
NH2
Amlodipine
• Longer duration of action than nifedipine • Single daily dose to manage hypertension Note: this compound is chiral!
7
05/03/2017
Due to difference in esters:
Cl MeO2C
Cl MeO2C
CO2Et N H
CO2Et N H
O
NH2
(R)
O
NH2
(S)
S – enantiomer is >1000 more active
First synthetic route: racemic
MeO2C
HOAc, piperidine
+ Cl O
Cl MeO2C
CO2Et + O
CHO
O
O
N3
NH4OAc EtOH, reflux 2.5 h
Cl MeO2C
H2 / Pd
CO2Et N H
O
Cl MeO2C
NH2
CO2Et N H
O
N3
8
05/03/2017
Later synthesis – access to single enantiomers: O CN
O
Cl O MeO2C
O
O +
N3
Cl NH2
CHO
MeO2C N H
reflux, 2 h
CN
O
O N3
NaOH, rt, 2 h
Cl Cl
NaO
O
OMe
MeO2C
MeO2C
OMe
N H
N H
O
*
CO2H
O
O N3
N3
Can now separate diastereoisomers * Ester groups now differentiated – provides a handle
Separate diastereoisomers, then:
Cl
Cl
O MeO2C
1., 2.
O N H
MeO2C
CO2Et
OMe O
N H N3
O
NH2
1. EtOH, NaOEt – transesterification 2. H2 / Pd
9
05/03/2017
Side effects possible with this class of compound Grapefruit Juice – effect on felodipine
5mg tablet with juice: felodipine stays in plasma longer Without juice
Inhibits metabolism:
Cl
Cl
Cl
H3C
Cl
CO2CH3
H3CO2C N H
CYP3A4
CO2CH3
H3CO2C
CH 3
H3C
N
CH3
D.G. Bailey, et al.; Br J Clin Pharmacol 1998, 46:101-110
Synthesis of Diltiazem OMe
S
O O
N O N
• A benzothiazepine: originally developed as anti-depressant • Side effect noted: potent coronary vasodilation • Hence used in angina/hypertension (Viagra far from the first successful ‘side effect’ drug)
10
05/03/2017
Original synthetic route: racemic approach HS
CO2Me
CO2Me
[O]
OMe NO2
O2N
O
S
heat HO
CO2Me
OMe
OMe
resolve OMe NO2 S
OMe
H MeO2C
H OH
S
O O
N O N
OMe
OMe NH2
NO2
S
i) NaOH
S
H
H MeO2C
ii) H2 Pd-C
H OH
heat
H OH
HO2C
*
OMe
S OMe
OMe OH
S
O O
N
N H
Ac2O
S
*
i) NaH Cl
OH N
O N
O
O
N
N
Q - what are mechanisms of steps marked: *
11
05/03/2017
Later asymmetric route: Sharpless Asymmetric Epoxidation OAc
OAc
SHARPLESS
OAc
i) [O] ii] Me2SO4
*KEY*
O
O
HO
HO
CO2Me
py.HCl source of Cl HS
OMe
OMe NO2
Similar to racemic route
O2N
S
H Cl
H MeO2C
H OH
MeO2C
H OH
NB - Write brief notes on Sharpless asymmetric epoxidation of allylic alcohols
Synthesis of Verapamil
NC MeO
N
MeO
OMe OMe
• First calcium channel blocker to be licensed in USA • At the time mechanism of action unknown • Sold as racemate, even though (S) isomer more active
12
05/03/2017
CN
CN
i) NaNH2
MeO
ii) iPr-Br
MeO
MeO
MeO
NC
MeO
i) NaNH2
MeO
ii) allyl-Br
i) B2H6/H2O2 hydroboration /oxidation
MeO
MeO
MeO
NC
MeO
NC
OH
2 potential pathways to introduce amine fragment:
13
05/03/2017
Original racemic route
MeO
i) NaNH2
CN
MeO
N
+
CN
iPr-Br
MeO
OMe
Cl
MeO
OMe
NaNH2
NC N
MeO
OMe OMe
MeO
Resolution used to access single enantiomers:
MeO
i) base
CO2Me
i) base
MeO CO2Me
iPr-I
MeO
MeO Br
MeO
MeO
CO2Me
KOH
MeO CO2H
MeO
NC MeO MeO
N
RESOLVE
MeO
chiral amine "salt"
MeO
CO2H
OMe OMe
14
05/03/2017
steps
hydroboration MeO
MeO
MeO
MeO CO2R
CO2R
MeO
OH
MeO
HN
CN
Cl
OMe
OMe
NC
N
MeO
OMe
S MeO
OMe
Q - Suggest reagents and look up a mechanism for “hydroboration” of an alkene
Useful references Nifedipine: US Patent, 1969, 3,485,847 Amlodipine: J. Med. Chem., 1992, 35, 3341. Diltiazem: Tetrahedron, 1994, 50, 4323. Verapamil J. Org. Chem., 1987, 52, 1309
15...